
Hematologist

No OPD information available
Anemia
COVID-19
Hemolytic Transfusion Reaction
Multiple Myeloma
Myelodysplastic Syndrome (MDS)
Severe Acute Respiratory Syndrome (SARS)
Thrombocytopenia
ABO Incompatibility
Acute Myeloid Leukemia (AML)
Aplastic Anemia
Autoimmune Hemolytic Anemia
B-Cell Lymphoma
Beta Thalassemia
Blood Clots
Bone Marrow Transplant
Burkitt Lymphoma
Cardiac Tamponade
Chronic Lymphocytic Leukemia (CLL)
Classical Hodgkin Lymphoma
Common Variable Immune Deficiency
Congenital Afibrinogenemia
Congenital Hemolytic Anemia
Disseminated Intravascular Coagulation
Encephalitis
Familial Hypofibrinogenemia
Fetal and Neonatal Alloimmune Thrombocytopenia
Follicular Lymphoma
Gastrointestinal Bleeding
Hemoglobinopathy
Hemolytic Anemia
High Potassium Level
Hodgkin Lymphoma
Hysterectomy
Iron Deficiency Anemia
Leukemia
Monoclonal Gammopathy of Undetermined Significance (MGUS)
Non-Hodgkin Lymphoma
Paroxysmal Cold Hemoglobinuria
Paroxysmal Nocturnal Hemoglobinuria (PNH)
Placenta Previa
Pneumonia
Primary Mediastinal B-Cell Lymphoma (PMBCL)
Sepsis
T-Cell Lymphoma
Thalassemia
Venous Thromboembolism (VTE)
West Nile Virus Infection
Zika Virus Disease
Zoe K. Mcquilten is a female medical professional who helps patients with various health conditions like anemia, COVID-19, leukemia, and blood disorders. She is skilled in treating diseases that affect the blood and immune system, such as multiple myeloma, thrombocytopenia, and autoimmune hemolytic anemia.
Patients trust Zoe K. Mcquilten because she communicates effectively and compassionately with them. She listens to their concerns, explains treatment options clearly, and shows empathy towards their needs. Patients appreciate her caring and supportive approach to healthcare.
Zoe K. Mcquilten stays updated with the latest medical knowledge and research to provide the best possible care for her patients. She regularly attends conferences, reads medical journals, and collaborates with other healthcare professionals to stay informed about advancements in the field.
In her work, Zoe K. Mcquilten collaborates closely with colleagues and other medical professionals to ensure comprehensive and coordinated care for patients. She values teamwork and believes in the importance of working together to achieve the best outcomes for patients.
Zoe K. Mcquilten's dedication and expertise have had a positive impact on many patients' lives. Her commitment to providing high-quality care and her innovative treatment approaches have helped improve the health and well-being of those she serves.
One of Zoe K. Mcquilten's notable publications is "Development of a New Longitudinal Ordinal Outcome for Clinical Trials in ECMO Patients," published in the American Journal of Respiratory and Critical Care Medicine. She has also conducted clinical trials, such as the study evaluating the safety and efficacy of antifibrinolytics in patients with hematological malignancies.
In summary, Zoe K. Mcquilten is a compassionate and skilled healthcare professional who is dedicated to improving the lives of her patients through expert medical care, effective communication, and ongoing learning and research.
Enrollment Status: Completed
Published: December 12, 2024
Intervention Type: Drug
Study Drug: Tranexamic acid
Study Phase: Phase 3
